• Saracatinib (AZD0530): Mapping Src Biology to Translation

  2026-08-22

  Saracatinib (AZD0530) is a dual Src family kinase and Abl inhibitor that connects biochemical selectivity with measurable changes in cancer cell proliferation, migration, invasion, and xenograft biology. This thought-leadership guide explains how to use the compound as a mechanistic research tool while extending the discussion to the context-dependent role of Src signaling in synaptic plasticity and ketamine response.

• Olsalazine Sodium: Applied Research Workflows

  2026-08-21

  Olsalazine Sodium connects LTB4-driven inflammation assays with colorectal cancer tumor model workflows and exploratory xenobiotic-clearance studies. Its aqueous formulation, defined chemotaxis potency, and paired molecular-functional readouts support practical assay design while highlighting important cross-domain limitations.

• SR-202: Selective PPARγ Antagonist Research Guide

  2026-08-21

  SR-202, chemically named (S)-(4-chlorophenyl)(dimethoxyphosphoryl)methyl dimethyl phosphate, is a selective PPARγ antagonist for mechanistic studies of adipogenesis, insulin resistance, and inflammation. Preclinical evidence connects PPARγ blockade with altered adipocyte and macrophage phenotypes, but no clinical efficacy has been established.

• Atorvastatin C6405 for Reliable Cell Assays

  2026-08-20

  This scenario-driven guide explains how Atorvastatin (SKU C6405) can support controlled cell viability, proliferation, cytotoxicity, vascular biology, and ferroptosis workflows. It combines formulation-aware handling, product-reported activity values, assay interpretation, and practical vendor-selection criteria for biomedical laboratories.

• O-GlcNAc–HUWE1–TfR1 Axis in Preeclampsia

  2026-08-20

  The reference study identifies an O-GlcNAc–HUWE1–TfR1 pathway linking placental ferroptosis, iron uptake, and trophoblast syncytialization in preeclampsia. Its findings suggest that restoring O-GlcNAc modification can reduce iron-driven trophoblast injury and improve adverse pregnancy phenotypes in mice, while also defining important limits for translation beyond placental models.

• Rimonabant (SR141716) in CB1 Research

  2026-08-19

  Rimonabant (SR141716) provides a selective CB1 blockade strategy for separating endocannabinoid signaling from adenosine A2A-mediated effects in pain, appetite, inflammation, and neurobiology assays. This guide presents practical workflows, control designs, formulation advice, and troubleshooting for reproducible preclinical studies.

• CRTC–CREB Sensing of Proteotoxic Stress in Drosophila

  2026-08-19

  The reference study identifies the CRTC–CREB axis as a conserved transcriptional sensor that converts proteasome inhibition, reactive oxygen species, and JNK signaling into a protective proteostasis response. Its combination of compound screening, transcriptomics, genetic manipulation, and Huntington’s disease models shows how stress-responsive transcription can improve protein folding, aggregate clearance, motility, and lifespan in Drosophila.

• Acridine Orange hydrochloride: Technical Guide

  2026-08-18

  Acridine Orange hydrochloride supports DNA and RNA differential staining in cell cycle analysis, apoptosis detection, and flow cytofluorometric nucleic acid staining. It is intended for validated nucleic-acid workflows, not as a universal viability marker, non-nucleic-acid probe, or long-term solution reagent.

• TBK1-Driven Microglia Pyroptosis in Diabetic Neuropathy

  2026-08-18

  Liao and colleagues identify activated TANK-binding kinase 1 (TBK1) in spinal microglia as a mechanistic driver of painful diabetic neuropathy through noncanonical NF-κB signaling, NLRP3 inflammasome activation, and pyroptosis. The study links molecular intervention with behavioral and tissue-level outcomes, supporting TBK1 inhibition as a testable strategy for neuroinflammatory complications of diabetes.

• Chemistry of Silybin: Structure, Methods, and Implications

  2026-08-17

  The review Chemistry of silybin assembles more than five decades of research on the isolation, stereochemical assignment, separation, synthesis, and derivatization of this central milk thistle flavonolignan. Its most consequential contribution is showing how silybin A and silybin B can be treated as chemically distinct compounds, which improves interpretation of structure–activity and assay results.

• Genistein: Tyrosine Kinase Research Guide

  2026-08-16

  Genistein, also known as 5,7-dihydroxy-3-(4-hydroxyphenyl)chromen-4-one, is a research compound used to study protein tyrosine kinase signaling, growth-factor responses, and cancer chemoprevention. Product data report micromolar inhibition of tyrosine kinase activity and EGF-mediated mitogenesis, while a separate peer-reviewed study establishes that mechanical-stress-induced autophagy depends strongly on cytoskeletal integrity.

• Lyso-Tracker Red for Mechanistic Lysosome Assays

  2026-08-15

  Lyso-Tracker Red enables live-cell measurement of acidic lysosome behavior during nanoparticle uptake, immune-cell activation, and drug-response studies. This practical guide connects lysosomal imaging with the CLam/OVA vaccine-adjuvant study while emphasizing controls, quantitative workflows, and interpretation limits.

• ABT-737 in Reliable Apoptosis Assays

  2026-08-15

  This scenario-based guide explains how ABT-737, SKU A8193, can address common variability in cell viability, proliferation, and apoptosis assays. It covers mechanism, solvent compatibility, starting conditions, data interpretation, and practical vendor-selection criteria for biomedical laboratories.

• Irinotecan (CPT-11): Applied Research Workflows

  2026-08-14

  Irinotecan (CPT-11) combines enzyme-dependent activation with topoisomerase I inhibition, making it useful for mechanistic DNA damage studies, colorectal cancer cell line inhibition, and translational tumor models. This workflow-focused guide covers exposure design, solubility control, assay timing, xenograft considerations, and troubleshooting.

• Angiotensin II: Practical Research Protocol

  2026-08-14

  Angiotensin II provides a controlled peptide stimulus for receptor-signaling studies, vascular smooth muscle cell hypertrophy research, and vascular remodeling models. This guide explains preparation, cell and minipump workflows, and quality controls; the product is for research use only and should not be used for diagnosis, treatment, or direct clinical dosing.

449 records 7/30 page Previous Next First page 上5页 678910 下5页 Last page